Company Active LTD

Company profile

Affimer Limited

UK company 08458974, incorporated on 25 March 2013.

Home | Avacta Life Sciences Limited

We develop safe and efficacious drugs, and powerful research and diagnostic tools, based on our proprietary Affimer and pre|CISION platforms

Company number
08458974
Incorporated
25 Mar 2013
Companies House status
Active

Company identity

Founded / incorporated
25 March 2013

Company number 08458974

Verify at Companies House
Legal name
AFFIMER LIMITED
Company type
LTD
Region
Unknown
Registered address
Unknown
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

2 levels 1 ultimate controller
1
Company Active LTD
Affimer Limited
CRN 08458974
2
Direct controller Active LTD
3
Ultimate controller Active PLC
Avacta Group PLC
CRN 04748597

Company events

Reference milestones and recent Companies House filing stream events.

1 event
25 Mar
2013

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2014
Funded years
2014
Age at first award
1 years

Projects

2014 GRD Proof of Concept

Affimers: a novel biotherapeutic platform for the treatment of cancer

1 Jun 2014 to 31 Aug 2016

Awarded
£35,647
Total cost £59,411

Promexus is a new biotechnology company which will be developing a novel human therapeutic protein (the Affimer) that will address some of the shortcomings of the current antibody based drugs. Antibodies have been very successful at treating a wide range of human disease such as asthma, arthritis and cancer, but they are expensive to produce and because o...

Product types

GRD Proof of Concept